Partners Otsuka America, Inc.
Partners Proteus Digital Health
Start Date 2017-00-00
End Date 2022-00-00
Is Current yes
Amount 88,000,000 USD
Goods “The $88 million investment — which includes equity and other payments that Otsuka will be making as part of this collaboration — will really be around developing a portfolio of digital and antipsychotic drugs,” Mehra said. “The first one people are already aware of: Abilify, on the MyCite platform.”
Notes health plans have shown interest in the sensor-equipped platform, including Magellan Health, Desert Oasis Healthcare, and most recently Children’s Health.
Updated over 7 years ago